Because the basis of our hypothesis is that both the CBFB/RUNX1 complex and p53 are tumor suppressors for breast cancer, we focused on 33 shared targets that were regulated by the CBFB/RUNX1 complex and p53 in the same direction. Here, CBFB is linked to neoplasm.